Best Medical Weight Loss Clinics in Huffman TX [2026]

Huffman itself has very few dedicated medical weight loss providers. The community is primarily served by small family medicine and urgent care practices along FM 2100 and the surrounding rural roads, none of which specialize in structured obesity medicine programs. For Huffman residents, this means planning for a drive, which is a normal part of healthcare access in this part of Harris County.

The FM 1960 corridor in Humble is the most accessible hub. It runs east-west across the north Houston suburbs and has developed a meaningful concentration of medical practices over the past decade, including several dedicated weight loss and GLP-1 clinics that serve the surrounding rural and suburban communities. Humble is roughly 15 miles from central Huffman via FM 2100 to FM 1960, making it the practical go-to for medical weight loss care.

Kingwood, to the south along the San Jacinto River, has a growing selection of healthcare services including practices that offer semaglutide and tirzepatide programs, a slightly closer option for residents in the southern part of 77336.

The clinics that serve Huffman residents, primarily those along the FM 1960 corridor in Humble and in Kingwood, generally offer both semaglutide and tirzepatide programs, with compounded formulations as the dominant option for out-of-pocket patients.

Semaglutide, the active ingredient in Wegovy and Ozempic, produces average weight loss of around 15% of body weight in clinical trials. Tirzepatide, the active ingredient in Zepbound and Mounjaro, acts on both GLP-1 and GIP receptors and has shown average weight loss exceeding 20% of body weight in the SURMOUNT trial series. Both are weekly self-administered injectable medications, with dose escalation over several months to reach a therapeutic maintenance level.

Compounded semaglutide and tirzepatide, prepared by licensed 503A and 503B pharmacies, are widely available through Humble-area clinics and represent the primary option for patients without insurance coverage. These formulations deliver the same active ingredient as brand-name products at significantly lower cost. Some Humble-area practices offer telehealth follow-ups after an initial in-person visit, which reduces the number of trips Huffman residents need to make for ongoing care. Ask when booking whether the clinic supports telehealth follow-ups and which labs they work with in the Huffman or Kingwood area for routine blood draws.

Because Huffman residents are drawing from the same regional clinics as Humble and Kingwood patients, pricing is consistent with the broader northeast Houston suburban market. Compounded semaglutide typically runs $199 to $350 per month, with lower-dose starter months at the bottom of that range and higher therapeutic doses pushing toward the upper end. Compounded tirzepatide generally costs $250 to $450 per month.

Brand-name Wegovy lists at approximately $1,300 to $1,450 per month without insurance. Brand-name Zepbound is in a similar price range, though Eli Lilly's savings programs provide meaningful relief: the Zepbound Direct self-pay program starts around $349 per month for single-dose vials, and the Lilly savings card can reduce copays substantially for commercially insured patients.

When comparing clinics in Humble and Kingwood, ask specifically what is included in the monthly program fee. Some clinics bundle the consultation, lab work, and all follow-up visits into a flat monthly rate, which is the most straightforward pricing model. Others charge for these items separately, which can add meaningfully to the total cost. For Huffman residents who are already absorbing a drive to access care, understanding total program costs upfront avoids surprises.

Insurance coverage for GLP-1 medications is available through many commercial plans active in Harris County, but it requires prior authorization and eligibility varies by plan. The major insurers serving the Huffman and northeast Houston area, Blue Cross Blue Shield of Texas, Aetna, and UnitedHealthcare, cover Wegovy and Zepbound on a significant share of employer-sponsored commercial plans when prior authorization criteria are met.

Standard prior authorization criteria require a documented BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or sleep apnea. Your physician submits clinical documentation supporting the diagnosis and medical necessity. Decisions typically come back within three to ten business days via the insurer's online portal.

Texas Medicaid does not currently cover GLP-1 medications for weight management. ACA marketplace plans cover GLP-1 medications at lower rates than employer-sponsored plans. For Huffman residents without coverage, the $199 to $350 monthly range for compounded semaglutide through an Humble-area clinic is the most practical option. Clinics along the FM 1960 corridor that process large volumes of GLP-1 prescriptions generally have the most current knowledge about which specific employer plans are approving claims in this area.

Since Huffman residents are typically choosing a clinic in Humble or Kingwood rather than one down the street, it is worth evaluating options carefully before committing, switching clinics mid-program means repeating intake paperwork and creating gaps in care.

Board certification is the most reliable credential to verify. Look for a physician board-certified in internal medicine, family medicine, endocrinology, or obesity medicine through the American Board of Obesity Medicine (ABOM). ABOM certification indicates specific training in weight management beyond general medical licensing.

Lab work on intake is a safety baseline, not optional. Before your first prescription, a responsible clinic should run a metabolic panel, HbA1c, thyroid function (TSH), and lipid panel. GLP-1 medications carry an FDA boxed warning for thyroid tumor risk based on animal data, and a personal or family history of medullary thyroid carcinoma is a contraindication. Labs also catch undiagnosed diabetes and thyroid conditions that affect treatment planning.

Telehealth follow-up capability is worth prioritizing given the drive involved. Ask whether the clinic handles routine dose-check visits via video after the initial in-person consultation, and whether they have a lab partner near Huffman or Kingwood for routine blood draws.